The point is that Purdue's Oxycontin is highly addictive and that addicts and normal people were using the drug....continuing the addictive cycle....and that normal people need something for pain other than highly addictive oxycontin.....thus the USPTO approved 216 for all opioids.....soon there will be no need to prescribe opioids that aren't abuse resistant.
Market Data 
Markets 
AI
